Aidan King
Fondatore presso Fountain Healthcare Partners Ltd.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Albert W. Gianchetti | M | 59 |
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
| Jennifer Augusti | F | - |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
| Joël Crouzet | M | 65 |
Ermium Therapeutics SAS
 Ermium Therapeutics SAS BiotechnologyHealth Technology Ermium Therapeutics SAS is a biotechnology company, which develops therapies for auto-immune diseases. It specializes in conditions such as systemic lupus erythematous, multiple sclerosis, and rheumatoid arthritis. The company was founded by Joël Crouzet and Jean-Philippe Herbeuval in June 2019 and is headquartered in Paris, France. | 5 anni |
| Ronald Crystal | M | - |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | 11 anni |
| Ruthanne Monaghan | F | - |
Fountain Healthcare Partners Ltd.
 Fountain Healthcare Partners Ltd. Investment ManagersFinance Fountain Healthcare Partners Ltd. (Fountain) is venture capital firm, founded in 2008 by Manus Rogan and Aidan King. The firm is headquartered in Dublin, Ireland.
University College Dublin
| 8 anni |
| Todd K. Rosengart | M | - |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | 11 anni |
| Manus Rogan | M | 55 |
Fountain Healthcare Partners Ltd.
Fountain Healthcare Partners Ltd. Investment ManagersFinance Fountain Healthcare Partners Ltd. (Fountain) is venture capital firm, founded in 2008 by Manus Rogan and Aidan King. The firm is headquartered in Dublin, Ireland. | - |
| Justin Lynch | M | - |
Fountain Healthcare Partners Ltd.
Fountain Healthcare Partners Ltd. Investment ManagersFinance Fountain Healthcare Partners Ltd. (Fountain) is venture capital firm, founded in 2008 by Manus Rogan and Aidan King. The firm is headquartered in Dublin, Ireland. | 16 anni |
| Igor Shvets | M | - |
Trinity College Dublin
| 33 anni |
| John Paul de Koning | M | 55 |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
| Ena Prossner | M | 58 |
Fountain Healthcare Partners Ltd.
Fountain Healthcare Partners Ltd. Investment ManagersFinance Fountain Healthcare Partners Ltd. (Fountain) is venture capital firm, founded in 2008 by Manus Rogan and Aidan King. The firm is headquartered in Dublin, Ireland. | 16 anni |
| Alan Colowick | M | 61 |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | 6 anni |
| Daniel Hetu | M | - |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
| Fiona MacLaughlin | M | - |
Syndesi Therapeutics SA
 Syndesi Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Syndesi Therapeutics SA develops novel therapeutics for cognitive impairment which includes Alzheimer’s disease, dementias, and cognitive impairment associated with schizophrenia. The company is headquartered in Louvain-la-Neuve, Belgium. | 4 anni |
| Glenn Batchelder | M | 63 |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
| Fouad Azzam | M | 57 |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
| Nikhil Thatte | M | - |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
| Lizzie Ngo | M | - |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
| Tania Papkovskaia | F | - |
Fountain Healthcare Partners Ltd.
Fountain Healthcare Partners Ltd. Investment ManagersFinance Fountain Healthcare Partners Ltd. (Fountain) is venture capital firm, founded in 2008 by Manus Rogan and Aidan King. The firm is headquartered in Dublin, Ireland. | 5 anni |
| Jean-Philippe Herbeuval | M | - |
Ermium Therapeutics SAS
Ermium Therapeutics SAS BiotechnologyHealth Technology Ermium Therapeutics SAS is a biotechnology company, which develops therapies for auto-immune diseases. It specializes in conditions such as systemic lupus erythematous, multiple sclerosis, and rheumatoid arthritis. The company was founded by Joël Crouzet and Jean-Philippe Herbeuval in June 2019 and is headquartered in Paris, France. | 5 anni |
| Philip Janiak | M | - |
Corteria Pharmaceuticals
 Corteria Pharmaceuticals Pharmaceuticals: MajorHealth Technology Corteria Pharmaceuticals is a privately held French company founded in 2021 that focuses on developing transformative therapies for the treatment of worsening and acute decompensated heart failure, sarcopenia, and obesity subpopulations. The company is based in Paris, France. The company's strategy involves innovative patient stratification and target identification. Corticotropin-releasing hormone receptor 2 (CRF2) is a plasma membrane receptor widely expressed in the cardiovascular, renal, and metabolic systems, and in proof of concept studies in heart failure patients and preclinical heart failure models, CRF2 agonists have been shown to improve cardiac function and reduce pulmonary congestion. The CEO is Philip Janiak. | - |
| A. Davis | M | 57 |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Mark Iwicki | M | 57 |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | - |
| George Martin | M | 65 |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 10 anni |
| Brian Farrell | M | - |
Trinity College Dublin
University College Dublin
| 7 anni |
| Menghisteab Bairu | M | 63 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 10 anni |
| Nigel Bernard John Clerkin | M | 51 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 16 anni |
| Fergus Lynch | M | - |
Trinity College Dublin
| 7 anni |
| Sean Patrick Mitchell | M | 56 |
Trinity College Dublin
| 5 anni |
| Andrea Franz | F | 62 |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | - |
| Hugh O'Neill | M | - |
University College Dublin
| 5 anni |
| Ben Hurley | M | - |
Trinity College Dublin
| 8 anni |
| Brien Dave O' | M | - |
University College Dublin
| 5 anni |
| Raj Shah | M | 46 |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | - |
| Damien McDevitt | M | 57 |
Trinity College Dublin
| 7 anni |
| Lars Ekman | M | 74 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 11 anni |
| Martin Freed | M | 63 |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | 5 anni |
| Richard Batycky | M | 56 |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | 5 anni |
| Scott Martin | M | - |
Trinity College Dublin
| 5 anni |
| David Hirsch | M | 53 |
Velicept Therapeutics, Inc.
 Velicept Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Velicept Therapeutics, Inc. manufactures biopharmaceutical products. The firm offers Solabegron, which is used for the treatment of overactive bladder in women and irritable bowel syndrome. The company was founded in 2015 and is headquartered in Wayne, PA.
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | 9 anni |
| Paul Murray | M | - |
University College Dublin
| 15 anni |
| Briain Morris | M | - |
University College Dublin
| 4 anni |
| James W. Young | M | 79 |
Chrono Therapeutics, Inc.
 Chrono Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Chrono Therapeutics, Inc. produces transdermal drug products. It is a pharmaceutical company with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery that offers real-time behavioral support. The company was founded by Guy DiPierro in 2004 and is headquartered in Hayward, CA. | - |
| Kieran McGowan | M | 80 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 16 anni |
| Declan Coyne | M | - |
University College Dublin
| 5 anni |
| Kyran McLaughlin | M | 80 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 16 anni |
| Luis Malavé | M | 61 |
Palyon Medical Corp.
 Palyon Medical Corp. Medical SpecialtiesHealth Technology Palyon Medical Corp. develops medical devices for the treatment of chronic pain, spasticity and other neurological diseases. The company was founded by Greg David, David A. Present and Klaus G. Lederer on May 16, 2003 and is headquartered in Santa Clarita, CA. | 13 anni |
| Shane Cooke | M | 61 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 10 anni |
| Donal Carroll | M | 48 |
University College Dublin
| 4 anni |
| Cleere Karl | M | - |
University College Dublin
| 3 anni |
| Alan Xavier Hudson | M | - |
University College Dublin
| 4 anni |
| Jonathan Dalton | M | - |
University College Dublin
| 4 anni |
| Patricia Keogh | F | - |
Trinity College Dublin
| 4 anni |
| Fiona Dawson | F | 58 |
Trinity College Dublin
| 4 anni |
| Ruairi O'Neill | M | - |
University College Dublin
| 4 anni |
| Graham Joseph Murphy | M | - |
Trinity College Dublin
| 4 anni |
| David Sharpe | M | - |
Trinity College Dublin
| 4 anni |
| Eben Tessari | M | 42 |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | 1 anni |
| Daragh Phelan | M | - |
University College Dublin
| 3 anni |
| John Ruane | M | - |
University College Dublin
| 3 anni |
| Feei Horng Wong | M | 56 |
Trinity College Dublin
| 4 anni |
| Simon Forsyth | M | - |
University College Dublin
| 4 anni |
| Kieran McLoughlin | M | - |
Trinity College Dublin
| 4 anni |
| Aisling Boland | F | - |
University College Dublin
| 4 anni |
| Cormac Gunne | M | - |
University College Dublin
| 3 anni |
| Niall Arthur O'Keeffe | M | - |
University College Dublin
| 4 anni |
| Padraig Owens | M | - |
University College Dublin
| 4 anni |
| Fui Chan Ten | M | 60 |
Trinity College Dublin
| 5 anni |
| Maria McMenamin | F | - |
University College Dublin
| 4 anni |
| Keelin McNamara | F | - |
Trinity College Dublin
| 4 anni |
| Garo Armen | M | 71 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 2 anni |
| Frank Cunneen | M | - |
University College Dublin
| 4 anni |
| Smyth Pete | M | - |
University College Dublin
| 5 anni |
| Stewart P. Skelly | M | 49 |
University College Dublin
| 4 anni |
| David Bolger | M | - |
Trinity College Dublin
| 4 anni |
| Joseph T. Kennedy | M | 56 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 3 anni |
| Timothy Nelson | M | 60 |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | 1 anni |
| Mary K. Pendergast | F | 73 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 5 anni |
| Conor Savio Muldoon | M | - |
Trinity College Dublin
| 4 anni |
| John Bohill | M | - |
Trinity College Dublin
| 4 anni |
| Ian Hunter | M | - |
University College Dublin
| 2 anni |
| William Prendergast | M | - |
University College Dublin
| 4 anni |
| Damhnait Ni Chinneide | F | 50 |
University College Dublin
| 1 anni |
| Alriona Costigan | F | - |
University College Dublin
| 4 anni |
| Alan Robinson | M | - |
Trinity College Dublin
| 4 anni |
| Carolyn Kenny | M | - |
Trinity College Dublin
| 3 anni |
| Edward Moss-Hughes | M | 58 |
Trinity College Dublin
| 1 anni |
| Kenneth Kinsella | M | 58 |
Trinity College Dublin
| 4 anni |
| Niall Sheehan | M | - |
University College Dublin
| 4 anni |
| Nick Hayes | M | - |
Trinity College Dublin
| 4 anni |
| Roger L. Hawley | M | 71 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 1 anni |
| Eamonn Sinnott | M | - |
University College Dublin
| 2 anni |
| Diarmaid Cunningham | M | 49 |
University College Dublin
| 4 anni |
| Fintan Whelan | M | - |
University College Dublin
| 1 anni |
| Joseph Newell | M | - |
University College Dublin
| 4 anni |
| James Bailey | M | - |
University College Dublin
| 4 anni |
| Colman Stephenson | M | - |
Trinity College Dublin
| 4 anni |
| Gavin McKeown | M | - |
University College Dublin
| 3 anni |
| John P. Mahony | M | - |
University College Dublin
| 3 anni |
| Laura Heuston | F | - |
University College Dublin
| 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Irlanda | 70 | 70.00% |
| Stati Uniti | 27 | 27.00% |
| Francia | 3 | 3.00% |
| Belgio | 1 | 1.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Aidan King
- Contatti personali
